David Murdoch

Dr. David Murdoch

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in AIDS Research and Therapy
Verified
Journal Article
Open access
PDF file
CWCatherine Mary Worsley
Catherine Mary Worsley
MSMelinda S Suchard
Melinda S Suchard
WSWendy S Stevens
Wendy S Stevens
ARAnnelies Van Rie
Annelies Van Rie
DMDavid Murdoch
David Murdoch
Immune reconstitution inflammatory syndrome (IRIS) is an important complication of HAART in sub-Saharan Africa, where opportunistic infections (OIs) including mycobacteria and cryptococcus are common. The immune system's role in HIV infected patients is complex with cytokine expression strongly influencing HIV infection and replication.

8 February 2012 in Cytometry Part A
Verified
Journal Article
Open access
PDF file
DMDavid Murdoch
David Murdoch
JSJanet S. Staats
Janet S. Staats
KWKent J. Weinhold
Kent J. Weinhold
This panel was optimized for the enumeration and phenotypic characterization of T regulatory cells (Tregs) within the CD4+ T‐cell pool using human peripheral blood mononuclear cells (PBMC) using intranuclear and intracellular staining methods. The panel was optimized for HIV+ clinical trial specimens through the use of HIV‐infected and normal donor PBMC. Because the panel is to be used in the context of testing cryopreserved PBMC obtained from multiple sites participating in clinical trials, it was essential to develop an assay that performed well using cryopreserved PBMC. Other tissue types have not been tested. © 2012 International Society for Advancement of Cytometry.

10 January 2024 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
PDF file
AMAshokkumar Manickam
Ashokkumar Manickam
WMWenwen Mei
Wenwen Mei
JPJackson J Peterson
Jackson J Peterson
YHYuriko Harigaya
Yuriko Harigaya
DMDavid Murdoch
David Murdoch
EBEdward P. Browne
Edward P. Browne
Despite the success of antiretroviral therapy, human immunodeficiency virus (HIV) cannot be cured because of a reservoir of latently infected cells that evades therapy. To understand the mechanisms of HIV latency, we employed an integrated single-cell RNA sequencing (scRNA-seq) and single-cell assay for transposase-accessible chromatin with sequencing (scATAC-seq) approach to simultaneously profile the transcriptomic and epigenomic characteristics of ∼ 125,000 latently infected primary CD4+ T cells after reactivation using three different latency reversing agents. Differentially expressed genes and differentially accessible motifs were used to examine transcriptional pathways and transcription factor (TF) activities across the cell population. We identified cellular transcripts and TFs whose expression/activity was correlated with viral reactivation and demonstrated that a machine learning model trained on these data was 75%–79% accurate at predicting viral reactivation. Finally, we validated the role of two candidate HIV-regulating factors, FOXP1 and GATA3, in viral transcription. These data demonstrate the power of integrated multimodal single-cell analysis to uncover novel relationships between host cell factors and HIV latency.

1 July 2014 in Biomicrofluidics
Verified
Journal Article
Open access
PDF file
WSWyatt Shields
Wyatt Shields
CLCarissa E. Livingston
Carissa E. Livingston
BYBenjamin B. Yellen
Benjamin B. Yellen
GLGabriel P. López
Gabriel P. López
DMDavid Murdoch
David Murdoch
We present a simple microchip device consisting of an overlaid pattern of micromagnets and microwells capable of capturing magnetically labeled cells into well-defined compartments (with accuracies >95%). Its flexible design permits the programmable deposition of single cells for their direct enumeration and pairs of cells for the detailed analysis of cell-cell interactions. This cell arraying device requires no external power and can be operated solely with permanent magnets. Large scale image analysis of cells captured in this array can yield valuable information (e.g., regarding various immune parameters such as the CD4:CD8 ratio) in a miniaturized and portable platform.

23 July 2007 in Infection
Verified
Journal Article
Closed access
PDF file
NTN. Tabatabaei
N. Tabatabaei
JSJ. Stout
J. Stout
PGP. Goldschmidt-Clermont
P. Goldschmidt-Clermont
DMDavid Murdoch
David Murdoch

4 April 2024 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JDJingzhong Ding
Jingzhong Ding
ANAnh Tram Nguyen
Anh Tram Nguyen
KLKurt Lohman
Kurt Lohman
MHMichael T. Hensley
Michael T. Hensley
DPDaniel Parker
Daniel Parker
YLYongmei Liu
Yongmei Liu
BACKGROUND: Preclinical studies suggest that cholesterol accumulation leads to insulin resistance. We previously reported that alterations in a monocyte cholesterol metabolism transcriptional network (CMTN) — suggestive of cellular cholesterol accumulation — were cross-sectionally associated with obesity and type 2 diabetes (T2D). Here, we sought to determine whether the CMTN alterations independently predict incident prediabetes/T2D risk, and correlate with cellular cholesterol accumulation. METHODS: Monocyte mRNA expression of 11 CMTN genes was quantified among 934 Multi-Ethnic Study of Atherosclerosis (MESA) participants free of prediabetes/T2D; cellular cholesterol was measured in a subset of 24 monocyte samples. RESULTS: During a median 6-year follow-up, lower expression of 3 highly correlated LXR target genes — ABCG1 and ABCA1 (cholesterol efflux) and MYLIP (cholesterol uptake suppression) — and not other CMTN genes, was significantly associated with higher risk of incident prediabetes/T2D. Lower expression of the LXR target genes correlated with higher cellular cholesterol levels (e.g., 47% of variance in cellular total cholesterol explained by ABCG1 expression). Further, adding the LXR target genes to overweight/obesity and other known predictors significantly improved prediction of incident prediabetes/T2D. CONCLUSION: These data suggest that the aberrant LXR/ABCG1-ABCA1-MYLIP pathway (LAAMP) is a major T2D risk factor and support a potential role for aberrant LAAMP and cellular cholesterol accumulation in diabetogenesis. FUNDING: The MESA Epigenomics and Transcriptomics Studies were funded by NIH grants 1R01HL101250, 1RF1AG054474, R01HL126477, R01DK101921, and R01HL135009. This work was supported by funding from NIDDK R01DK103531 and NHLBI R01HL119962.